| Patents for C07D - Heterocyclic compounds (10,420) |
|---|
| 09/30/2004 | CA2733837A1 Purification of taxanes and taxane mixtures using polyethyleneimine-bonded resins |
| 09/30/2004 | CA2519853A1 Process for the preparation of 7-amino (p-hydroxyphenylglycylamido) cephem compounds |
| 09/30/2004 | CA2518707A1 Compounds, a process for their preparation and their use as dyes and pigments |
| 09/29/2004 | EP1159272B1 A process for the preparation of 1,4,7,10-tetraazacyclododecane |
| 09/29/2004 | EP1062201B1 Halogenated amidino amino acid derivatives useful as nitric oxide synthase inhibitors |
| 09/29/2004 | EP1012140B1 New amidino derivatives and their use as thrombin inhibitors |
| 09/29/2004 | CN1533387A 1-phenysulfonyl-1,3-dihydro-2H-indole-2-one derivatives, their preparation and their therapeutic use |
| 09/29/2004 | CN1168717C Novel intermediates for prepn. of antihisatminic piperidine derivatives |
| 09/28/2004 | US6797719 Osteoporosis; antilipemic agents; anticancer agents |
| 09/23/2004 | WO2004081007A1 Pyridyloxymethyl and benzisoxazole azabicyclic derivatives |
| 09/23/2004 | WO2004080998A1 Imidazol-4-yl-ethynyl-pyridine derivatives |
| 09/23/2004 | WO2004080960A2 Methods and compositions for the enzymatic synthesis of gangliosides |
| 09/23/2004 | WO2004080959A2 Process for the preparation of dexmethylphenidate hydrochloride |
| 09/23/2004 | WO2004080958A2 Process to tetrahydrotriazolopyrazines and intermediates |
| 09/23/2004 | WO2004080957A2 Use of adnf polypeptides for treating anxiety and depression |
| 09/23/2004 | WO2004043913A3 Hetero-substituted benzimidazole compounds and antiviral uses thereof |
| 09/23/2004 | WO2004021989A3 Imidazolopyridines and methods of making and using the same |
| 09/23/2004 | US20040186305 loading or injecting mixture of taxanes on column comprising a polyethyleneimine-bonded silica resin, wherein taxanes are derived from one or more Taxus plants, and the taxanes are not derived solely from Taxus brevifolia, eluting, recovering |
| 09/23/2004 | US20040186133 preferably antagonists used in the therapeutic and/or preventive treatment of disfunctions of the heart, kidney, respiratory system, central nervous system |
| 09/23/2004 | US20040186090 New amidino derivatives and their use as thrombin inhibitors |
| 09/23/2004 | CA2518171A1 Methods and compositions for the enzymatic synthesis of gangliosides |
| 09/22/2004 | EP1460075A1 Substituted 8-Pyridinyl-6,7,8,9-Tetrahydropyrimido[1,2-a]Pyrimidin-4-one and 8-Phenyl-6-7,8,9-Tetrahydropyrimido[1,2-a]Pyrimidin-4-one derivatives |
| 09/22/2004 | EP1458701A1 Method for the preparation of escitalopram |
| 09/22/2004 | EP1458690A1 5,6-diaryl-pyrazine-2-amide derivatives as cb1 antagonists |
| 09/22/2004 | EP1458689A1 Aryloxyphenyl and arylsulfanylphenyl derivatives |
| 09/22/2004 | EP1458677A1 3-phenyl-2-arylalkylthiopropionic acid derivatives as selective agonists of ppar-alpha |
| 09/22/2004 | EP1458376A1 Darifenacin for use in the treatment of urgency induced by overactive bladder |
| 09/22/2004 | CN1167687C Arylpyridazinones as prostaglandin endoperoxide H synthase biosynthesis inhibitors |
| 09/22/2004 | CN1167420C Azabanzimidazole-based compounds for modulating serine/threonine protein kinase function |
| 09/21/2004 | US6794402 Bicyclic cyclohexylamines and their use as NMDA receptor antagonists |
| 09/21/2004 | CA2033143C Alkyl esters of 5-heterocyclic-pyridine-2,3-dicarboxylate acids, 5-heterocyclic 2-(2-imidazoline-2-yl)pyridines, useful as herbicidal agents and methods for the preparation thereof |
| 09/16/2004 | WO2004078733A1 Quinazolines useful as modulators of ion channels |
| 09/16/2004 | WO2004078714A2 Processes for preparing imidazoquinoxalinones, heterocyclic-substituted imidazopyrazinones, imidazouinoxalines and heterocyclic-substituted imidazopyrazines |
| 09/16/2004 | WO2004078713A2 Morpholino based activity mapping |
| 09/16/2004 | WO2004078710A2 An enhanced system for electronic funds transfer and elimination of the payee’s need for encryption and privacy |
| 09/16/2004 | WO2004078709A2 METHOD FOR PREPARING 17 α-ACETOXY-11β-(4-N,N-DIMETHYLAMINOPHENYL)-19-NORPREGNA-4,9-DIENE-3,20-DIONE, INTERMEDIATES THEREOF, AND METHODS FOR THE PREPARATION OF SUCH INTERMEDIATES |
| 09/16/2004 | WO2004078116A2 P38 inhibitors and methods of use thereof |
| 09/16/2004 | WO2004062562A3 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 09/16/2004 | US20040180964 anti-obestic activity; Neuropeptide Y antagonist |
| 09/16/2004 | US20040180947 Sulfonamide compounds and pharmaceutical use thereof |
| 09/16/2004 | US20040180936 having an inhibitory activity on calpains and/or a trapping activity on reactive oxygen species; inflammatory and immunological diseases; disorders of the central or peripheral nervous system |
| 09/16/2004 | US20040180932 Benzothiophenes, formulations containing same, and methods |
| 09/16/2004 | US20040180928 Process for the preparation of dexmethylphenidate hydrochloride |
| 09/16/2004 | US20040180912 for promoting the release of parathyroid hormone, e.g. for preventing or treating bone conditions which are associated with increased calcium depletion or resorption or in which stimulation of bone formation and calcium fixation in the bone is desirable |
| 09/16/2004 | US20040180898 chemical reduction reaction |
| 09/16/2004 | US20040180896 P38 inhibitors and methods of use thereof |
| 09/16/2004 | US20040180894 Benzamide inhibitors of the P2X7 receptor |
| 09/16/2004 | US20040180878 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use |
| 09/16/2004 | US20040180875 Obesity, anorexia, bulemia, depression, anxiety, psychosis, schizophrenia, migraine, addictive behavior, obsessive-compulsive disorder, sexual disorders |
| 09/16/2004 | US20040180096 Ceramic based nanoparticles for entrapping therapeutic agents for photodynamic therapy and method of using same |
| 09/16/2004 | CA2517844A1 Quinazolines useful as modulators of ion channels |
| 09/15/2004 | EP1457490A1 5-membered N-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 09/15/2004 | EP1456199A1 Salt forms of e-2-methoxy-n-(3-(4-(3-methyl-pyridin-3-yloxy)-phenylamino)-quinazolin-6-yl)-allyl)-acetamide, its preparation and its use against cancer |
| 09/15/2004 | EP1455756A1 Pharmaceutical nanoparticulate composition of a tachykinin receptor antagonist |
| 09/15/2004 | CN1529704A 3-(4-amidopyrrol-2-2ylmethlidene)-2-indolinone derivatives as protein kinase inhibitors |
| 09/15/2004 | CN1166668C Method for preparing substituted [1,4] diazepino (6,7,1-hi) indol-4-ones |
| 09/15/2004 | CN1166640C Substituted 1,2,3,4,5,6-hyxahydro-2,6-methano-3-benzazocine-10-oles, method for production and use thereof as medicaments |
| 09/14/2004 | US6790850 Thiazolo(4,5-d)pyrimidine compounds |
| 09/10/2004 | WO2004076458A1 Pyrazolo[1,5-a]pyrimidine derivatives |
| 09/10/2004 | WO2004076414A2 Novel compounds |
| 09/10/2004 | WO2004076412A2 Aminoheteroaryl compounds as protein kinase inhibitors |
| 09/10/2004 | WO2004076411A2 Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity |
| 09/10/2004 | WO2004076410A2 Polymorphs of pyrrole substituted 2-indolinone protein kinase inhibitors |
| 09/10/2004 | WO2004076406A2 Losartan potassium polymorphs and process for the preparation thereof |
| 09/10/2004 | WO2004060869A3 Methods and compositions for catalytic dna exchange in a sequence manner |
| 09/10/2004 | WO2004037783A3 Treatment of cognitive impairment using a selective dopamine d1 receptor agonist |
| 09/10/2004 | WO2003061652A8 3-(imidazolyl)-2-alkoxypropanoic acids as tafia inhibitors |
| 09/10/2004 | CA2517256A1 Aminoheteroaryl compounds as protein kinase inhibitors |
| 09/10/2004 | CA2516900A1 Polymorphs of pyrrole substituted 2-indolinone protein kinase inhibitors |
| 09/10/2004 | CA2516824A1 Pyrazolo[1,5-a]pyrimidine derivatives |
| 09/10/2004 | CA2516705A1 Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity |
| 09/09/2004 | US20040176462 NPY Y5 antagonist |
| 09/09/2004 | US20040176414 principle metabolite of cisapride; has both 5-HT3 antagonistic and 5-HT4 agonistic; devoid of central nervous system effects; separating racemic mixture by liquid chromatography over a chiral stationary phase |
| 09/09/2004 | US20040176401 preparing a 2-(N-methyl-N-methanesulfonylamino)pyrimidine by reacting a hydroxypyrimidine with an organic sulfonyl halide; without employing a toxic compound |
| 09/09/2004 | US20040176325 P38 MAP kinase inhibitors comprising indazole derivatives; antiinflammatory and antiproliferative agents; autoimmune, bone, and neurodegenerative disorders; viricides, infections |
| 09/09/2004 | US20040176324 Derivatives of 4,7-ethanothiopyrano[3,4-c]pyrrole-1,3-(2H)-dione, 4,7-epoxy-1H-isoindole-1,3(2H)-dione, and/or 4,7-ethano-1H-pyrrolo[3,4-c]pyridine-1,3(2H)-dione derivatives; autoimmune diseases; anticarcinogenic agents |
| 09/08/2004 | EP1453789A2 N,n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/08/2004 | EP1165505B1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 09/08/2004 | CN1527825A Method for the preparation of escitalopram |
| 09/08/2004 | CN1527821A Preparation of aminopyrimidine compounds |
| 09/08/2004 | CN1527816A New indole derivatives with 5-HT6 receptor affinity |
| 09/07/2004 | US6787549 For therapy of inflammatory bowel disease, ulcerative colitis, pyoderma gangrenosum, crohn's disease, irritable bowel syndrome, spastic dystonia, chronic pain, acute pain, celiac sprue, pouchitis, vasoconstriction, anxiety, panic disorder |
| 09/07/2004 | US6787535 Indole derivatives with 5HT6 receptor affinity |
| 09/02/2004 | WO2004074262A1 Hiv replication inhibiting pyrimidines and triazines |
| 09/02/2004 | WO2004074261A1 Hiv replication inhibiting pyrimidines and triazines |
| 09/02/2004 | WO2004074249A2 Synthesis of peloruside a and analogs thereof for use as antitumor agents |
| 09/02/2004 | WO2004074248A2 Isolation and structure of cribrostatin 6 |
| 09/02/2004 | WO2004074247A2 A1 adenosine receptor antagonists |
| 09/02/2004 | WO2004074242A2 Halogenated oxime derivatives and the use thereof as latent acids |
| 09/02/2004 | WO2004056324A3 Substituted tricyclic gamma-carbolines as serotonin receptor agonists and antagonists |
| 09/02/2004 | WO2004014851A3 Tyrosine kinase inhibitors |
| 09/02/2004 | WO2003099786A3 Aromatic sulfones and their medical use |
| 09/02/2004 | US20040171881 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/02/2004 | US20040171851 Process for the preparation of 5-carboxyphthalide |
| 09/02/2004 | US20040171848 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 09/02/2004 | US20040171847 From a pyrrolidinone compound; coloring high molecular weight material |
| 09/02/2004 | US20040171665 Novel polymorphic form IV and solvate; precipitation from ethyl acetate |
| 09/02/2004 | US20040171641 Arylpiperazines and their use as metalloproteinase inhibiting agents (MMP) |
| 09/02/2004 | US20040171612 Novel compounds with analgesic effect |
| 09/02/2004 | CA2516393A1 Synthesis of peloruside a and analogs thereof for use as antitumor agents |